Nova One Advisor
Pharmaceutical Chemicals Market Size, Share & Analysis Report, 2023-2032

Pharmaceutical Chemicals Market (By Product: Basic Building Blocks, Advanced intermediates, and Active ingredients; By Application: Cardiovascular, Neurology, Oncology, Infectious diseases, Metabolic system, Diabetes, Respiratory diseases, Gastrointestinal diseases, Musculoskeletal diseases, and Other)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

Status: Published Category: Healthcare Insight Code: 7726 Format: PDF / PPT / Excel

Content

The global pharmaceutical chemicals market size was exhibited at USD 120.44 billion in 2022 and is projected to hit around USD 239.15 billion by 2032, growing at a CAGR of 3.90% during the forecast period 2023 to 2032.

 pharmaceutical chemicals market size

Crucial factors accountable for market growth are:

  • Increasing demand for advanced drugs
  • Growing geriatric population
  • Rise in demand for the active pharmaceutical chemicals
  • Development of the neurological drugs
  • Easy availability of healthcare insurances
  • Government support for research and development activities
  • Advantages offered by pharmaceutical chemicals

The healthcare industry is flourishing on the back of increased disposable income of urban population and escalating percentage of geriatrics in the world’s population. Consequently, the demand for pharmaceuticals is on the rise, providing a strong traction to the global pharmaceutical chemicals market. Forming the basic ingredients for the manufacturing of medicines, the market for pharmaceutical chemicals functions under high safety standards

Rise in non-communicable diseases, aging population, life expectancy, improved income level a larger masses in BRICS nations, increased government expenditure on healthcare, and ongoing research and development are some of the key trends behind the growth of the pharmaceutical chemicals market.

Geographically, North America accounted for the maximum, 50.9%, share of the total demand in the global pharmaceutical chemicals market in 2022. The strength of the demand from North America can be ascribed to the increase in demand from consumer base in the region, primarily from the developed countries of the U.S. and Canada. The U.S. houses the headquarters and prominent shareholders of some of the leading companies operating in this market, which is also in the favor of the North America pharmaceutical chemicals market. Europe also served a prominent share of demand at 28.1% in the global pharmaceutical chemicals market in 2022 and is expected to flourish further during the forecast period. That being said, the analysts of the report have highlighted Asia Pacific as a region with tremendous opportunities, projecting the demand from the region to increment at an above-average CAGR of 11.7% during the forecast period of 2023 to 2032.  The global market share of Latin America and Middle East and Africa is expected to increase, but at a slow pace in the near future.

Pharmaceutical chemicals Market Segmentation

Product Type Application Type

Basic building blocks

Advanced intermediates

Active ingredients

Cardiovascular

Neurology

Oncology

Infectious diseases

Metabolic system

Diabetes

Respiratory diseases

Gastrointestinal diseases

Musculoskeletal diseases

Other

 

Pharmaceutical chemicals Market Key Players And Regions

Companies Profiled Regions Covered

BASF

Lonza

Porton Fine Chemicals

Dishman

Lanxess

Johnson Matthey

Vertellus Holdings

Jubilant Life Sciences

Hikal

Abbott

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa (MEA)

 

  • Insight Code: 7726
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: January 2023
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034
FAQ's

The global pharmaceutical chemicals market size was exhibited at USD 120.44 billion in 2022 and is projected to hit around USD 239.15 billion by 2032

The global pharmaceutical chemicals market is growing at a compound annual growth rate (CAGR) of 3.90% from 2023 to 2032.

BASF, Porton Fine Chemicals, Lonza, Johnson Matthey, Dishman, Lanxess, Vertellus Holdings, Jubilant Life Sciences, Hikal, Abbott